Saturday, July 8, 2017

EBC-46, sourced from the Australian rainforest, that has been shown to cure various types of cancers


In 2014 news spread about a miracle berry extract called EBC-46, sourced from the Australian rainforest, that has been shown to cure various types of cancers including breast and prostate in humans and animals.
Scientists at QIMR Berghofer Medical Research Institute in Queensland have used an experimental drug produced from the seeds of the rainforest plant, Blushwood tree (Hylandia Dockrillii), which exclusively grows in far north Queensland, to cure solid cancer tumours in pre-clinical trials.
Already the drug has been used to successfully destroy or shrink tumours in pets and animals – including dogs, cats and horses and even Tasmanian Devils, while human trials are imminent.’
These results were discovered in an eight-year study led by Dr. Glen Boyle, from the QIMR Berghofer medical research institute in Brisbane. In 75% of cases, the cancer never returns. There were no side effects, and the compounds started working in five minutes, making cancerous melanoma and neck tumors disappear in a matter of days.
This is from an article published byCairns News in 2014:
“It’s a small molecule that actually works with the body to destroy cancer, rather than being a chemo-therapy approach which is acting, in many cases, against the body,” Q-Biotics CEO Victoria Gordon told Nine this week.
Q-Biotics are the company behind this discovery and are now looking to create a drug based treatment out of this:
This is from their website:
QBiotics is an Australian public unlisted life sciences company. We are in the business of development and commercialisation of pharmaceutical products that have the potential to address major health problems for humans and companion animals (dogs, cats and horses). Our products are new chemical entities which we source from Australia’s pristine tropical rainforests.

What Exactly Is EBC-46?

This is from wikipedia:
‘Tigilanol tiglate (USAN), previously known as EBC-46 is an experimental drug candidate being studied pre-clinically by the Australian company Ecobiotics (specifically its drug discovery subsidiary Qbiotics). It was discovered through an automated screening process of natural products by selecting increasingly purified fractions of plant extracts, based on their ability to produce the desired activity profile. This is then followed by artificial synthesis of the isolated compound to confirm its chemical structure. EBC-46 is a phorbol ester which, along with other related compounds, acts as a protein kinase C regulator.
From reading into this it seems that the system they follow is to test the plant extract that works, then they isolate the compound to find out the chemical structure so they can synthesise it to make a drug.

How Big Pharma Banks Off Stuff That Exists In Nature

In pharmacy school we were taught that many drugs started off as substances found in nature to work, that could be then isolated and synthesised for commercial purposes.
It later became very apparent that the reason drug companies do this is so that they can create a patent that means only they had the license to synthesise the drug resulting in billions of dollars in profit for the company.
Similar things are happening right now in the medical marijuana field with drug companies trying to isolate extracts from cannabis so that they can make drugs out of them.
Statins are another example. A common chinese herbal medicine from heart health is red rice yeast. It has been used for years in China to prevent blood clots and generally improve circulation and the health of the heart. The active ingredient is lovastatin. The drug companies then created a multibillion dollar statin business off the back of this.
Merck actually owns the rights to this substance that exists in nature:
In 1998, the FDA placed a ban on the sale of dietary supplements derived from red yeast rice, which naturally contains lovastatin, arguing that products containing prescription agents require drug approval. Judge Dale A. Kimball of the United States District Court for the District of Utah, granted a motion by Cholestin’s manufacturer, Pharmanex, that the agency’s ban was illegal under the 1994 Dietary Supplement Health and Education Act because the product was marketed as a dietary supplement, not a drug.
So now the same thing is about to happen with this miracle berry extract sourced from the Australian Blushwood Berry, that at present only grows in Queensland, Australia.

No comments:

Post a Comment

Famous Post

ORIGINAL FOR TEA LOVERS #SHORTS